ProShare Advisors
CRBU icon

ProShare Advisors’s Caribou Biosciences CRBU Stock Holding History

ProShare Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9K Buy
+15,279
New +$30.2K ﹤0.01% 1896
2025
Q2 		– Sell
-17,810
Closed -$16.3K – 2098
2025
Q1 		$16.3K Sell
17,810
-5,360
-23% -$6.97K ﹤0.01% 2046
2024
Q4 		$36.8K Buy
23,170
+2,284
+11% +$4.59K ﹤0.01% 2217
2024
Q3 		$40.9K Buy
20,886
+4,345
+26% +$8.9K ﹤0.01% 1997
2024
Q2 		$27.1K Sell
16,541
-4,366
-21% -$14K ﹤0.01% 1793
2024
Q1 		$107K Buy
20,907
+1,704
+9% +$10.5K ﹤0.01% 1812
2023
Q4 		$110K Buy
19,203
+3,728
+24% +$18.4K ﹤0.01% 1769
2023
Q3 		$74K Buy
15,475
+4,107
+36% +$25.5K ﹤0.01% 1679
2023
Q2 		$48.3K Buy
11,368
+538
+5% +$2.42K ﹤0.01% 1776
2023
Q1 		$57.5K Sell
10,830
-1,433
-12% -$8.93K ﹤0.01% 1658
2022
Q4 		$77K Buy
12,263
+963
+9% +$8.57K ﹤0.01% 1695
2022
Q3 		$119K Buy
11,300
+507
+5% +$4.72K ﹤0.01% 1525
2022
Q2 		$59K Sell
10,793
-4,973
-32% -$38K ﹤0.01% 1682
2022
Q1 		$145K Buy
15,766
+2,856
+22% +$30.1K ﹤0.01% 1962
2021
Q4 		$195K Buy
+12,910
New +$251K ﹤0.01% 2043

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ProShare Advisors's CRBU Position: Q2 2026 in Review

ProShare Advisors opened a new position in Caribou Biosciences (CRBU) in Q2 2026: 15,279 shares worth $26.9K. The stake represents ﹤0.01% of the portfolio and ranks #1896 among its holdings. This is a return to the name: ProShare Advisors previously reported a position in CRBU as recently as Q1 2025.

ProShare Advisors first reported a position in CRBU in Q4 2021 and has held it in 15 quarters since. The position peaked at $195K in Q4 2021. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • ProShare Advisors held 15,279 shares of Caribou Biosciences worth $26.9K as of Q2 2026.
  • Caribou Biosciences was a new ProShare Advisors position in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1896 holding.
  • ProShare Advisors first reported a position in Caribou Biosciences in Q4 2021 and has held it in 15 quarters since.
  • ProShare Advisors's Caribou Biosciences position peaked at $195K in Q4 2021.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.